It has been known for some time that there is a wide variation in take-up of treatment options for patients with breast cancer across the country and there are perceptions (undocumented) that some centres offer 'better' treatments than others. It is not clear if this translates into a survival advantage. The management of rarer cancers such as germ cell tumours and childhood leukaemia requiring intensive treatments have been concentrated in specialist centres with improvements in survival rates (McCarthy, 1975; Stiller, 1988) .
The Yorkshire Breast Cancer Group (YBCG) was established 20 years ago by a group of surgeons with an interest in the disease and initially collected data on prognostic factors. It has sponsored trials into conservation therapy and has generally increased interest in management of the disease across Yorkshire. Not all surgeons treating breast cancer are members.
This paper examines firstly the treatment patterns of patients with breast cancer across Yorkshire related to district of residence, surgeon (whether or not they are members of the YBCG) and radiotherapist for the years 1978-92 and, secondly, a prospective audit of facilities available in each district. There are constraints to a study such as this -only treatments within 9 weeks of diagnosis were recorded. Most districts did not have access to a medical oncologist at this time. Patiets and methods Cancer registry data for the years 1978-92 were used. The cancer registry recorded 70 data items for each patient record during this period. These included extent of disease at presentation, consultants and hospitals of management during the initial 9 week treatment period, treatment modalities used and date and cause of death. The use of radiotherapy was recorded, as was the use of chemotherapy and hormone therapy. Surgical procedure codes were grouped as mastectomy or lumpectomy (the latter included partial mastectomy) for the purposes of this study, and only the first two operations undergone by each patient were included in the analysis. Patients receiving lumpectomy followed by mastectomy during the initial treatment period were categorised as receiving the latter only. All cases of primary breast cancer diagnosed by cytology or histology were included, including multiple primary breast tumours. Concerns over completeness of data collection were addressed and a cross-check was, therefore, made with one district where all cases had been prospectively registered on a separate system. Only treatments starting within 9 weeks of the date of first definitive treatment were included.
As part of the cancer registry each district has its own clerk who is responsible for checking the notes and extracting data, although the initial registration routinely comes from the pathology laboratory. The recently described probability of recurrence of extreme data method (Palmer, 1993) Figure 6 ).
Results
Only 625 of the 27 216 registrations between 1978 and 1992 were DCOs (2.3%). In 84.2% (22 903 cases) the disease was confirmed histologically (Table I) . The cross-check between cancer registry data and those held on a stand-alone system in one district revealed 113 out of 116 invasive cancers to be correctly registered for 1991 (97.4%). The age-standardised incidence of breast cancer in Yorkshire was 103 per 100 000 , with one district having 80-90% this rate and one between 110% and 120%. The overall 10 year survival for patients with breast cancer in Yorkshire was 37% with a median survival of 6.4 years (10 year relative survival of 51.3%).
The regional age-standardised mortality was 47.38 per 100 000 . which was 90% compared with the national average for this period. One distnrct had consistently better mortality rates (80-90% of the regional average), three between 110% and 120% and one > 120% of this figure (P<0.01).
The regional mastectomy rate is shown in Figure 1 . There were wide variations between districts with a mastectomy rate ranging from 13% to 87%. When districts were ranked for percentage of cases treated by mastectomy there was significant variation (P<0.0001; Palmer's method) suggesting that some persistently carried out more mastectomies than others. The gradual adoption of conservation therapy (lumpectomy ± radiotherapy) can be seen in Figure 2 . Again there are significant differences between distnrcts (P = 0.037; Palmer's method). Cross-examination of a sample of cancer registry treatment data with clinical trials data for the period 1981-86 indicated a shortfall of less than 2% in the recording of both surgical procedures and radiotherapy treatments (unpublished Figure  6 . The prospective enquiry into facilities available across the region showed (Table II) 1978 1980 1982 1984 1986 1988 1990 1992 1979 1981 1983 1985 1987 1989 1991 Figre (Table I ). Only one district had all the facilities listed and three had only three of the listed criteria. The number of patient visits to achieve a diagnosis varied widely (from 1 to 4). This was dependent, to some extent, on the facilities available locally. Units with a dedicated breast unit were more likely to achieve an early diagnosis than those where patients had to reattend for each investigation. With a dedicated breast unit the majority of cases of symptomatic breast cancer should be diagnosable at first visit.
The treatments offered varied widely, with significantly higher levels of mastectomy in some districts. This is similar to the findings of a postal survey that showed geographic variations in the likelihood of a patient receiving a mastectomy (Morris, 1992 (Anon, 1986) laborative Group 1992) clearly showed that premenopausal patients with node-positive disease benefited from such treatment but these lessons are only now beginning to be addressed by some. This may be because of organisational problems with unwillingness to provide such services or may be secondary to clinicians' individual perceptions of the cost-benefit ratio for chemotherapy. Farrow et al. (1992) have shown geographical variation in the treatment of 'early' breast cancer in the United States, and a study from Illinois has shown that small urban hospitals are likely not to provide comprehensive diagnosis and treatment (Hand et al., 1991) . In our study we could find no difference between teaching and non-teaching districts when they were analysed for rates of mastectomy or radiotherapy uptake.
A recent report from Japan (Izuo & Ishada, 1994) Information about the quality of local services will be increasingly important in the future as contracts of provision of services are made. It is clear that a degree of specialisation needs to occur, with breast work going to one or two surgeons in each district, but a decision also needs to be made as to whether the patient is best served by each district providing a comprehensive range of services or whether subregional groupings should occur. Diagnostic clinics might, perhaps, be based in each district with in-patient care being based in one centre. The majority of breast work is outpatient, and if high standard breast cinics were developed the number of in-patient episodes could be reduced. We found that some districts are still admitting patients for diagnostic biopsies as fine-needle cytology was not used and others were admitting patients for staging investigations such as bone scans despite clear evidence that they serve no useful purpose in patients with stage I disease.
Guidelines for the management of symptomatic breast disease are in preparation by a number of groups and should allow a fuller debate about the placement and extent of breast services. These have been drawn up by the British Association for Surgical Oncology and the British Breast Group and are currently out for discussion. It is likely that purchasers of health care will require evidence of practice according to such guidelines in placing contracts for this work.
Treatment for patients with breast cancer did vary significantly according to residential district, with suboptimal therapy being administered in some districts in the past.
